Suzanne Cole
Impact in
- Hematology top 10%
- Pharmacy top 10%
Papers in
-
- Renal cell carcinoma treatment 12
- Oncology 17
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- John G. Jones (1 shared paper)Jeffrey C. Long (2 shared papers)Michael A. Solomon (1 shared paper)A. Dean Sherry (1 shared paper)Craig R. Malloy (1 shared paper)Connie J. Mulligan (1 shared paper)Keith Hunley (1 shared paper)C.R. Pace-Asciak (1 shared paper)
- Journals
- Journal of Clinical Oncology (16 papers)European Urology Oncology (3 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Blood (2 papers)JAMA Network Open (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Suzanne Cole
48 papers receiving 680 citations
Peers
Comparison fields: 5 of 110
- Hematology 81
- Pharmacy 30
- Oncology 132
- Public Health, Environmental and Occupational Health 131
- Pulmonary and Respiratory Medicine 142
Countries citing papers authored by Suzanne Cole
This map shows the geographic impact of Suzanne Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Cole more than expected).
Fields of papers citing papers by Suzanne Cole
This network shows the impact of papers produced by Suzanne Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Cole. The network helps show where Suzanne Cole may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 100 | |
| 2 | 2003 | 77 | |
| 3 | 2004 | 77 | |
| 4 | 2022 | 43 | |
| 5 | 2009 | 38 | |
| 6 | 2022 | 33 | |
| 7 | 1975 | 27 | |
| 8 | 2010 | 25 | |
| 9 | 2019 | 24 | |
| 10 | 2021 | 24 | |
| 11 | 2021 | 23 | |
| 12 | 2016 | 19 | |
| 13 | 2006 | 16 | |
| 14 | 2022 | 15 | |
| 15 | 2018 | 15 | |
| 16 | 2021 | 15 | |
| 17 | 2023 | 13 | |
| 18 | 2016 | 11 | |
| 19 | 2001 | 9 | |
| 20 | 2023 | 9 |
About Suzanne Cole
Suzanne Cole is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 53 papers that have together received 702 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Renal cell carcinoma treatment (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Urinary and Genital Oncology Studies (7 papers), Renal and related cancers (5 papers), Obesity, Physical Activity, Diet (5 papers), Cancer Genomics and Diagnostics (4 papers) and MRI in cancer diagnosis (3 papers). The work is most often cited by research in Hematology (81 citations), Pharmacy (30 citations), Oncology (132 citations), Public Health, Environmental and Occupational Health (131 citations) and Pulmonary and Respiratory Medicine (142 citations). Suzanne Cole has collaborated with scholars based in United States, Canada and France. Frequent co-authors include John G. Jones, Jeffrey C. Long, Michael A. Solomon, A. Dean Sherry, Craig R. Malloy, Connie J. Mulligan, Keith Hunley, C.R. Pace-Asciak, Hagop M. Kantarjian and Nicolette I. Teufel‐Shone. Their work appears in journals such as Journal of Clinical Oncology, European Urology Oncology, Urologic Oncology Seminars and Original Investigations, Blood and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.